Glatstein E - Search Results

1

Early-stage Hodgkin disease in a 24-year-old woman.

Peters C, Glatstein E, Vose J, Thomas LC, Morris GJ. Peters C, et al. Among authors: glatstein e. Semin Oncol. 2011 Dec;38(6):705-13. doi: 10.1053/j.seminoncol.2011.06.003. Semin Oncol. 2011. PMID: 22082755 No abstract available.

2

Hodgkin disease?

Evans AE, Collins MH, Glatstein E, Feola GP. Evans AE, et al. Among authors: glatstein e. Med Pediatr Oncol. 1998 Apr;30(4):252-8. doi: 10.1002/(sici)1096-911x(199804)30:4<252::aid-mpo8>3.0.co;2-j. Med Pediatr Oncol. 1998. PMID: 9473761 No abstract available.

3

Outcomes after involved-field radiation therapy (IFRT) with or without rituximab in patients with early-stage low-grade non-Hodgkin lymphoma (NHL) staged with CT and PET.

Lukens JN, Nasta SD, Fram B, Glatstein E, Plastaras JP. Lukens JN, et al. Among authors: glatstein e. Am J Clin Oncol. 2014 Feb;37(1):35-40. doi: 10.1097/COC.0b013e31826106c9. Am J Clin Oncol. 2014. PMID: 22992623

4

Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.

Longo DL, Glatstein E, Duffey PL, Young RC, Hubbard SM, Urba WJ, Wesley MN, Raubitschek A, Jaffe ES, Wiernik PH, et al. Longo DL, et al. Among authors: glatstein e. J Clin Oncol. 1991 Jun;9(6):906-17. doi: 10.1200/JCO.1991.9.6.906. J Clin Oncol. 1991. PMID: 2033427 Clinical Trial.

5

Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials.

Bar Ad V, Paltiel O, Glatstein E. Bar Ad V, et al. Among authors: glatstein e. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1472-9. doi: 10.1016/j.ijrobp.2008.08.026. Int J Radiat Oncol Biol Phys. 2008. PMID: 19028275 Review.

6

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M. Lister TA, et al. Among authors: glatstein e. J Clin Oncol. 1989 Nov;7(11):1630-6. doi: 10.1200/JCO.1989.7.11.1630. J Clin Oncol. 1989. PMID: 2809679

7

The never-ending controversies in Hodgkin's disease.

Raubitschek A, Glatstein E. Raubitschek A, et al. Among authors: glatstein e. Int J Radiat Oncol Biol Phys. 1989 Nov;17(5):1115-7. doi: 10.1016/0360-3016(89)90166-1. Int J Radiat Oncol Biol Phys. 1989. PMID: 2808047 No abstract available.

8

Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.

Longo DL, Russo A, Duffey PL, Hubbard SM, Glatstein E, Hill JB, Jaffe ES, Young RC, DeVita VT Jr. Longo DL, et al. Among authors: glatstein e. J Clin Oncol. 1991 Feb;9(2):227-35. doi: 10.1200/JCO.1991.9.2.227. J Clin Oncol. 1991. PMID: 1988570

9

The case for combined-modality therapy for limited-stage Hodgkin's disease.

Hill-Kayser CE, Plastaras JP, Tochner Z, Glatstein E. Hill-Kayser CE, et al. Among authors: glatstein e. Oncologist. 2012;17(8):1006-10. doi: 10.1634/theoncologist.2012-0148. Epub 2012 Jul 17. Oncologist. 2012. PMID: 22807513 Free PMC article.

10

Radiation therapy of esophageal cancer.

Hancock SL, Glatstein E. Hancock SL, et al. Among authors: glatstein e. Semin Oncol. 1984 Jun;11(2):144-58. Semin Oncol. 1984. PMID: 6203175 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters